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Since its first isolation a century ago, the gut inhabitant Escherichia coli strain
Nissle 1917 has been shown to have probiotic activities; however, it is yet not fully
elucidated which differential factors play key roles in its beneficial interactions with
the host. To date, no metabolomics studies have been reported investigating the
potential role of small molecules in functional strain differentiation of Nissle from its
genetically close neighbors. Here, we present results of liquid chromatography coupled
to high-resolution mass spectrometry characterization of extracellular metabolomes
of E. coli strains as a proxy of their bioactivity potential. We found that phylogroup
B2 strains exported a more diverse arsenal of metabolites than strains of other
phylogroups. Zooming into the phylogroup B2 metabolome identified consistent
substantial differences between metabolic output of E. coli Nissle and other strains,
particularly in metabolites associated to the Argimine biosynthesis pathway. Nissle was
found to release higher levels of Ornithine and Citrulline whilst depleting greater amounts
of Arginine from the medium. Moreover, a novel Nissle-specific metabolite not reported
before in bacteria, 5-(Carbamoylamino)-2-hydroxypentanoic acid (Citrulline/Arginic Acid
related) was observed. Finally, Nissle, CFT073 and NCTC12241/ATCC25922 shared
the excretion of N5-Acetylornithine, whereas other strains released N2-Acetylornithine
or no N-Acetylornithine at all. Thus, we found substantial metabolic differences in
phylogenetically very similar E. coli strains, an observation which suggests that it is
justified to further investigate roles of small molecules as potential modulators of the
gut environment by probiotic, commensal, and pathogenic strains, including E. coli
Nissle 1917.
Keywords: Escherichia coli, Nissle 1917, probiotic, pathogenic, extracellular metabolome, mass spectrometry,
metabolomics
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INTRODUCTION
Escherichia coli is a highly diverse and versatile bacterial species
many representatives of which are common resident organisms
of the intestinal tract in homeothermic animals. E. coli can be
classified on the basis of many characteristics including their
ability to cause disease, frequently referred to as “pathotype”
(Robins-Browne et al., 2016). These include intra-intestinal
pathogenic (InPEC) and extra-intestinal pathogenic (ExPEC)
strains, exemplified respectively, by enterohaemorrhagic E. coli
(EHEC such as O157:H7) and uropathogenic E. coli (UPEC).
Although E. coli strains include significant pathogenic strains,
the majority of E. coli co-exist with their warm-blooded hosts in
commensal or mutualistic relationships. In addition, some E. coli
strains have been shown to possess overtly beneficial activities
and have been exploited as probiotic organisms (Wassenaar,
2016). Among these are E. coli strain Nissle 1917 (henceforth
referred to as Nissle) which has received much attention to
characterize its probiotic activities (Trebichavsky et al., 2010;
Alvarez et al., 2016; Sonnenborn, 2016; Wassenaar, 2016).
From applied and fundamental studies of Nissle it is
evident that its probiotic capacity is multi-faceted and involves
competition with pathogens (Huebner et al., 2011; Deriu
et al., 2013; Sassone-Corsi et al., 2016), promotion of mucosal
integrity (Hering et al., 2014; Wang et al., 2014), modulation of
intestinal innate defenses (Zyrek et al., 2007; Guzy et al., 2008;
Mondel et al., 2008), bioavailability of enteroendocrine effectors
(Nzakizwanayo et al., 2015) and modulation of peristaltic
contractions (Bär et al., 2009; Dalziel et al., 2015). These
activities correlate with the usage of this strain in amelioration
of acute and chronic enteric diseases (Henker et al., 2008;
Kruis et al., 2012; Losurdo et al., 2015; Scaldaferri et al.,
2016) and prevention and treatment of infectious diseases
(Kandasamy et al., 2017). In addition, Nissle and other
probiotic bacteria may exert benefits beyond the intestinal
tract (Mazzoli and Pessione, 2016).
Intriguingly, Nissle is phylogenetically closely-related
to clinically significant pathogenic strains, specifically
uropathogenic (UPEC) and other invasive (ExPEC) strains
(Dobrindt et al., 2010; Hancock et al., 2010; Vejborg et al.,
2010). Despite sharing many virulence factors (including
adhesins, toxins and effectors) with these related strains, Nissle is
clearly distinct in its interactions with host tissues although the
factors responsible remain incompletely characterized (Becker
et al., 2014). Much attention has focussed on macromolecular
structures [e.g., surface polysaccharides (Hafez et al., 2010)
and protein components such as adhesins and flagella (Schlee
et al., 2007)], and toxins. Besides siderophores involved in
iron acquisition, there has been less emphasis towards small
extracellular molecule components and their potential role in
bacterium-host interaction for Nissle.
The role of small molecules in bacterium-host interactions
has been an area of increasing research interest over recent
years (Donia and Fischbach, 2015). Whilst Nissle is the
most-studied probiotic since its discovery 100 years ago
(Sonnenborn, 2016; Wassenaar, 2016), its ‘core metabolism’
and the metabolites (other than siderophores) Nissle releases
into its environment have been largely overlooked so far. In
this study, a metabolomic survey of Nissle alongside other
E. coli strains from B2 and other phylogroups was performed.
Since the B2 phylogroup strains contained a high and unique
metabolite diversity, we postulated that E. coli Nissle 1917
(i) could possess metabolic characteristics that distinguish it
from other E. coli including phylogenetically closely-related
pathogenic strains and that (ii) these components could
contribute towards probiotic activities of Nissle. Towards this
goal, we used high-resolution LC-MS and LC-MS/MS approaches
to characterize extracellular metabolomes in a subset of E coli B2
phylogroup strains phylogenetically very close to Nissle, followed
by identifications and annotations of metabolites distinct for
Nissle. Our observations showed that Nissle exports distinct
Arginine biosynthesis-related metabolites, namely Citrulline, a
Citrulline analog, and Ornithine, whilst Arginic (Argininic) acid
was released by its close relatives. These results were validated
through an independent experimental study with extracellular
samples from these E. coli strains. This work underlines
that high-resolution mass spectrometry analyses combined
with fragmentation approaches are capable of accurately
characterizing bacterial metabolites and thus molecular bacterial
phenotypes. We conclude that small molecule extracellular
profiles show substantial differences between the probiotic and
pathogenic strains and that metabolites and yet undescribed
metabolic pathways may contribute to as yet undiscovered
unforeseen activities in bacterium-host interactions.
MATERIALS AND METHODS
Bacterial Isolates, Culture and Sample
Preparation
Escherichia coli strains MG1655, HS, TUV93-0, 042, O103:H2,
APEC O1, ABU83972, J96, 536, NCTC12241/ATCC25922 (this
strain is known under these two identifiers and will be denoted
as such throughout this study), CFT073 and Nissle 1917 were
all stored as glycerol stocks at −80◦C (see Supplementary
Table S1 for further details of strains). Stocks were revived
by culture on LB agar plates. Single colonies (in separate
replicate culture vessels) were cultured in DMEM (Low glucose
[D6046], Sigma-Aldrich) overnight at 37◦C without shaking.
Subsequently, each culture was diluted in DMEM to OD600
0.01 and grown to an OD600 of 0.8 (approximately 7 h).
Cultures were quenched in a dry ice/ethanol bath then
centrifuged at 4000 × g at 4◦C for 10 min. Supernatant
from each culture was recovered after centrifugation, passed
through a sterilization filter (0.2 µm), and mixed 1:4 with
chloroform/methanol (1:3). Triplicate samples of fresh media
were mixed 1:4 with chloroform/methanol (1:3). All samples
were incubated for 1 h at 4◦C with agitation then centrifuged
at 13,000 g for 3 min at 4◦C and solvent extracts recovered
and stored at −80◦C until mass spectrometry. Solvent extracts
(1:3:1 chloroform:methanol:water) of cells from selected strains
were as reference material for LC-MS/MS-based metabolite
annotations. Two fresh solvent samples were also collected as
solvent controls.
Frontiers in Microbiology | www.frontiersin.org 2 February 2019 | Volume 10 | Article 252
fmicb-10-00252 February 19, 2019 Time: 12:39 # 3
van der Hooft et al. Differential Metabolome Among Closely-Related E. coli
Genomic Analyses
Chromosome sequences for the E. coli B2 strains were
sourced directly from NCBI and have the following
assembly designations: CFT073 (GCA_000007445.1),
ABU83972 (GCA_000148365.1), 536 (GCA_000013305.1),
NCTC12241/ATCC25922 (GCA_000743255.1), Nissle 1917
(GCA_003546975.1), and J96 (GCA_000295775.2). The
genome sequence for strain MG1655 (GCA_000005845.2) was
also sourced for reference purposes. A strain-versus-strain
comparison of complete genome sequences was carried out using
the blastn tool with default settings. Also, all annotated protein
sequences for E. coli CFT073 were used to search for matches
in ABU83972, 536, NCTC12241/ATCC25922, Nissle 1917, J96,
and MG1655 using blastp to return “% sequence cover” and “%
sequence identity” results for every gene. Equivalence cut-off was
set as ≥ 90% sequence cover and identity.
Chemicals
HPLC-grade methanol, acetonitrile, and analytical reagent grade
chloroform were acquired from Fisher Scientific, Loughborough,
United Kingdom. HPLC grade H2O was purchased from VWR
Chemicals, Fountenay-sous-Bois, France. Ammonium carbonate
was acquired from Fluka Analytical (Sigma Aldrich), Steinheim,
Germany. Arginic acid was obtained from Sigma Aldrich.
Study Setup
For the initial study (Study 1), triplicate cultures were grown
and both whole cell extracts and supernatant were analyzed
with LC-MS. Selected samples of Study 1 were fragmented
separately. For the B2-focussed study (Study 2) and Validation
Study (Study 3), five replicate cultures were grown and analyzed.
In addition, the five replicates were pooled to generate LC-
MS/MS fragmentation data for each strain at the same time as
full scan MS data generation.
Analytical Instrumentation and Settings
Chromatography
The samples were analyzed using a Thermo Scientific Ultimate
3000 RSLCnano system (Thermo Scientific, CA, United States).
The pHILIC separation was performed with a SeQuant ZIC-
pHILIC column (150 × 4.6 mm, 5 µm) equipped with
the corresponding pre-column (Merck KGaA, Darmstadt,
Germany) – the column temperature was maintained at 25◦C.
A linear biphasic LC gradient was conducted from 80% B to 20%
B over 15 min, followed by a 2 min wash with 5% B, and 8 min
re-equilibration with 80% B, where solvent B is acetonitrile and
solvent A is 20 mM ammonium carbonate in water. The flow rate
was 300 µL/min, column temperature was held at 25◦C, injection
volume was 10 µL, and samples were maintained at 4◦C in the
autosampler (Creek et al., 2011).
Mass Spectrometry
Study 1 – E. coli B2 and other phylotypes
The LC system was coupled to a Thermo Scientific Exactive
Orbitrap mass spectrometer equipped with a HESI II interface
(Thermo Scientific, Hemel Hempstead, United Kingdom). The
set up was calibrated (Thermo calmix) in both ionization modes
and tuned for the lower m/z range before analysis. Full scan
(MS1) data was acquired in positive and negative switching
mode in profile mode at 50,000 resolution (at m/z 200) using
1 microscan, an AGC target of 106 cts, a maximum injection
time of 250 ms, with spray voltages +4.5 and -3.5 kV, capillary
temperature 275◦C, heater temperature of 150◦C, sheath gas flow
rate 40 a.u., auxiliary gas flow rate 5 a.u., sweep gas flow rate 5 a.u,
a full scan mass window of 70–1400 m/z, and using m/z 74.0964
(+) and m/z 112.98563 (−) as locking masses.
Studies 2 & 3 – B2-focussed and validation Study
The LC system was coupled to a Thermo Scientific Q-Exactive
Orbitrap mass spectrometer equipped with a HESI II interface
(Thermo Scientific, Hemel Hempstead, United Kingdom). The
set up was calibrated (Thermo calmix) in both ionization modes
and tuned for the lower m/z range before analysis. Full scan
(MS1) data was acquired in positive and negative switching
mode in profile mode at 35,000 resolution (at m/z 200) using
1 microscan, an AGC target of 106 cts, a maximum injection
time of 250 ms, with spray voltages +3.8 and -3.0 kV, capillary
temperature 320◦C, heater temperature of 150◦C, sheath gas
flow rate 40 a.u., auxiliary gas flow rate 5 a.u., sweep gas flow
rate 5 a.u, a full scan mass window of 70–1050 m/z, and using
m/z 74.0964 (+) and m/z 112.98563 (−) as locking masses. LC-
MS/MS fragmentation data of selected samples from Study 1 were
also obtained on this setup using similar settings.
Mass Spectrometry Fragmentation
Fragmentation data (LC-MS/MS) was obtained in positive and
negative ionization combined and separate fragmentation modes
as described in van der Hooft et al. (2016). Briefly, for separate
mode, a duty cycle consisted of one full scan (MS1) event and
one Top5 (or Top10) MS/MS (MS2) fragmentation event, with
full scan (MS1) resolution (at m/z 200) was set to 70,000, the
AGC target set to 1× 106, and the maximum injection time set to
120 ms. MS/MS (MS2) resolution (at m/z 200) was set to 17,500,
the AGC target set to 2 × 105, MS/MS maximum injection time
was set to 80 ms and the underfill ratio was set to 10%, with
a resulting intensity threshold of 2.5 × 105 cts. For combined
mode, a duty cycle consisted of two of the above events in positive
and negative ionization mode with the following modifications:
full scan (MS1) resolution (at m/z 200) was set to 35,000, MS/MS
resolution was set to 35,000, the AGC target was set to 1 × 105,
and the maximum MS/MS filling time was set to 120 ms with an
underfill ratio of 20%, resulting in an intensity threshold of 1.7×
105. Further settings were as specified for full scan analysis above.
Data Acquisition
Blank runs, quality control samples (beer and serum extracts
in accordance with standard procedures at Glasgow Polyomics)
to assess the performance of the mass spectrometer in terms of
chromatography and mass intensities, and three standard mixes
containing 150 reference compounds available from Glasgow
Polyomics were run to assess the quality of the mass spectrometer
and to aid in metabolite annotation and identification (Creek
et al., 2011). Pooled sample containing all samples was run prior
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to and across the batch every 6th sample to monitor the stability
and quality of the LC–MS run, whereas the samples were run in a
randomized order. Thermo Xcalibur Tune software (version 2.5)
was used for instrument control and data acquisition.
Immediately after acquisition, all raw files were converted
into mzXML format, thereby centroiding the mass spectra and
separating positive and negative ionization mode spectra into
two different mzXML files using the command line version
of MSconvert (ProteoWizard). Data quality assurance was
performed and accurate masses of standards were obtained
well within 3 ppm accuracy and intensities of the quality
control samples (a beer extract and a serum extract) were
within specifications.
Data Processing and Analysis
MzXML files were uploaded into IDEOM (Creek et al., 2012)
(Study 1) and PiMP1 (Studies 2 & 3). Both workflows rely on
XCMS (Smith et al., 2006) and MzMatch (Scheltema et al., 2011)
for LC-MS peak picking and alignment across samples. IDEOM
results in an Excel file that contains the results with PiMP being a
web-based tool.
Data Availability
All MzXML files used for this study were uploaded into the
GNPS repository (Wang et al., 2016) and can be accessed
through here: ftp://massive.ucsd.edu/ completed with for Study
1: MSV000081287, Study 2 MSV000081288, and Study 3
MSV000081289. Each data set consists of both full scan and
fragmentation data folders with each of them containing positive
ionization mode and negative ionization mode data folders.
Metabolite Annotation
Metabolites that matched to a standard and which fragmentation
spectrum matched with that of reference MS/MS spectra were
considered identified [Metabolite Identification Level 1 according
to the Metabolomics Standards Initiative (MSI) (Sumner et al.,
2007)]. If no such match was found, fragmentation spectra were
analyzed and compared to reference spectral databases, i.e., using
MzCloud2 and Metlin3 (Tautenhahn et al., 2012), and analyzed
using MaGMa4 (Ridder et al., 2013). Annotations resulting from
those analyses reported in this study are all of MSI level 2.
RESULTS
Metabolic Capacities of B2 Strains
versus Non-B2 Strains
The divergent gene content in the genomes of the B2 phylogroup
is thought to be amongst the most varied of all the E. coli
phylogroups (Touchon et al., 2009). To investigate if that could
contribute to the production of a diverse set of small molecules,





assessed (Study 1). Five of those strains belong to phylogroup
B2, whereas five other strains represented phylogroups A, B1, D,
or E (see Figure 1A). Observation of the metabolite output in
the extracellular metabolic profiles (Figure 1B) shows significant
differences in the number of discriminative measured metabolites
biosynthesised by the B2 compared with the non-B2 isolates
(p value< 0.001). Some B2 strains, for example Nissle and
CFT073, produced more than 20 metabolites which are not
biosynthesised and released by any strain in the non-B2 group
(Figure 1B) thus highlighting the diversity and uniqueness of
B2 small molecule profiles. We focussed on metabolic profiles
of B2 strains including probiotic and pathogenic strains to
investigate whether differentiating metabolites might contribute
to the differential phenotypes of those related strains.
Profiling of Extracellular Metabolome of
B2 Strains
The strains used for detailed B2 metabolome analysis are
phylogenetically closely related and have been demonstrated to
share phenotypic and pathogenicity determinants (Sun et al.,
2005; Hancock et al., 2010; Vejborg et al., 2010; summary
table presented as Supplementary Table S2). Nonetheless, these
strains display different phenotypes ranging from pathogenic to
probiotic, resulting at least in part from variation in genome
island content (Sun et al., 2005; Hancock et al., 2010; Vejborg
et al., 2010). Supernatants of five B2 strains complemented
with the widely used MG1655 strain were analyzed using
hydrophilic liquid chromatography (pHILIC) coupled to mass
spectrometry (MS) and MS fragmentation (MS/MS) analyses.
This comparative metabolomics profiling showed clear inter-
strain differences. Notably, the B2 phylogroup strains revealed
several identified metabolites (matching to standards run under
same conditions with the samples) to be present in the
supernatant at significantly different levels despite their close
phylogenetic relatedness. Amongst those metabolites, Ornithine
and Citrulline (see Supplementary Figure S1 for all structures
discussed in this paper) were amongst the most substantially
differential metabolites with all exhibiting higher levels in the
supernatant of the Nissle strain. Comparison of Ornithine and
Citrulline levels across all strains (and the DMEM medium
control) indicates that Nissle is clearly distinct in its metabolomic
output (Figure 2A). Concomitantly, Arginine was more depleted
from the media by Nissle than any other strain (Figure 2B).
We then also compared the levels of these three metabolites
in the first study (Figures 2C,D) which show consistent
changes with the B2 focused study. Moreover, a B2 focused
validation study (Study 3) was performed using samples from
cultures prepared separately – again showing similar metabolic
profiles for the Arginine biosynthesis pathway related metabolites
(Supplementary Figure S2). Thus, we could verify across three
independent experiments (Studies 1 to 3) that for the identified
metabolites the observed changes between Nissle and other
strains were consistent (Figure 2 and Supplementary Figure S2).
Hence, differences in the Arginine biosynthesis pathway-related
metabolites appear to be occurring in Nissle compared with the
other B2 strains examined.
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FIGURE 1 | (A) Escherichia coli phylogenetic distance of E. coli strains used in Study 1 (E. coli B2 and other phylotypes study) with each strain represented by a
colored circle – notice the tight grouping of the B2 strains in the upper right segment of the circle. (B) Numbers of released metabolites by phylogroup B2 strains that
were not found in non-B2 strains and vice versa following the same strain labeling as for (A). The results show that B2 strains possess a more diverse arsenal of
small molecules than the non-B2 strains measured in this study. In total, phylogroup B2 strains biosynthesise 46 metabolites that are not produced by non-B2
strains (red hatched diamond), whereas non-B2 strains produce only 6 metabolites that could not be detected in the B2 group (blue hatched diamond).
Given the low but consistent levels of Citrulline detected
in other B2 strains coupled with much lower (or lack of)
Ornithine levels, we assessed LC-MS/MS spectra from the
metabolites detected in Nissle and other strains (Figure 3).
Indeed, with the MS/MS spectrum for the C6H13N3O3
metabolite obtained from Nissle we could confirm Citrulline’s
structure (Figure 3A). However, the fragmentation spectra
obtained for the C6H13N3O3 metabolite in other B2 strains
such as CFT073 (Figure 3B) showed clear differences from
Citrulline. With manual interpretation of the resulting MS/MS
mass fragments, we annotated this metabolite as Arginic
acid (a.k.a. Argininic acid). Indeed, a standard confirmed
Arginic acid to elute 0.01 min from Citrulline (10.99 versus
11.00 min – well within 5% RT window to match peaks
across different samples) and its differential fragmentation
pattern from Citrulline. Thus, we observed differences in
Arginine biosynthesis-related metabolites uniquely associated
with Nissle.
Substantial Differences in Arginine and
Citrulline Related Metabolites in Nissle
In addition to Ornithine and Citrulline, we observed a metabolite
with the elemental formula of C6H12N2O4 to be consistently
present only in Nissle supernatant (Figure 4A). An LC-
MS/MS spectrum was obtained (Figure 4B) and with manual
interpretation and the use of MAGMa (Ridder et al., 2013),
we were able to structurally annotate the metabolite as 5-
(Carbamoylamino)-2-hydroxypentanoic acid (i.e., Citrulline
backbone with the NH2 group exchanged for an OH group).
Furthermore, we observed that N-acetylornithine was amongst
differential metabolites comparing Nissle to MG1655 that
is widely used as reference strain. Interestingly, with use
of LC-MS/MS, we established that Nissle, CFT073, and
NCTC12441/ATCC25922 all released N5-acetylornithine,
whereas other strains, either lacked this or released its more
commonly found isomer N2-acetylornithine (Figures 4C,D).
Figure 5 shows the phylogenetic relatedness of B2 strains
subject to the focussed study (Figure 5A) and salient steps
in the Arginine biosynthesis pathway (Figure 5B). The
B2 strains subject to the focussed metabolome analyses
all possess in common all Arginine biosynthesis genes;
strain MG1655 lacks arginine deiminase (EC 3.5.3.6,
c5350 in Figure 5) which directly inter-converts Arginine
and Citrulline.
In silico comparison of protein sequences from Nissle
against CFT073, NCTC12441/ATCC25922 and ABU_83972
(Supplementary Table S3) identified 65 proteins which
are present in Nissle but absent or divergent in the others.
Additionally, forty-eight proteins which are conserved in
CFT073, NCTC12441/ATCC25922 and ABU_83972 show
divergence in Nissle; of these, the majority (n = 36) of divergent
proteins differed by 1 to 3 amino acid substitutions whilst
the other 12 showed short in-frame deletion (CIW80_16080)
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FIGURE 2 | B2 focussed extracellular abundance of Arginine biosynthesis metabolites: (A) Average levels (counts/s) of Ornithine and Citrulline in DMEM medium and
supernatant of 6 E. coli strains including 5 from phylogroup B2 and the laboratory reference strain MG1655 determined from 5 replicates. Nissle releases
substantially higher levels of Ornithine and Citrulline into its environment than the other E. coli strains measured. (B) Level (counts/s) of Arginine in DMEM media and
supernatant of the 6 E. coli strains. Nissle was found to deplete more Arginine from the media than the other strains measured. Extracellular abundance of Arginine
biosynthesis metabolites identified in Study 1: (C) Average levels (counts/s) of Ornithine and Citrulline in DMEM medium and supernatant of 10 E. coli strains
including 5 from phylogroup B2 and 5 from other phylogroups. Nissle secretes both Ornithine and Citrulline in much higher quantities than the other 9 strains
measured. (D) Average levels (counts/s) of Arginine in DMEM media and supernatant of the 10 E. coli strains. Nissle was found to deplete more Arginine from the
media than the other 9 strains analyzed.
or insertion (CIW80_09850) or more substantial truncation.
Among these 113 proteins, only one (CIW80_01615) was
ascribed to an Arginine-related annotation, specifically
Arginine N-succinyltransferase.
DISCUSSION AND CONCLUSION
Interaction of bacteria with their environments (including
mammalian hosts) has evolved complex series of interplays.
From the bacterial perspective, major focus has been towards
surface structures [e.g., capsule polysaccharides (Hafez et al.,
2010), lipopolysaccharides (Grozdanov et al., 2002), fimbriae
(Kleta et al., 2014), flagella (Schlee et al., 2007)], exported
macromolecules (including toxins, effectors and their secretion
systems) and nutrient (e.g. iron and carbon source) acquisition
systems, all of which substantially contribute to niche occupation.
Although much less attention has been directed towards the
characterization of small exported molecules, recent years have
seen a rise in awareness of the potential significance of bacterial
metabolites in the interplay between bacteria and their hosts
(Donia and Fischbach, 2015) and metabolomics approaches were
applied to link metabolic potential to uropathogenic E. coli
virulence factors (AlRabiah et al., 2014).
Our study profiled extracellular metabolomes of closely- and
more distantly-related E. coli strains as proxy of their small
molecule interactions with their immediate environments, i.e.,
the host and co-colonizing bacteria. Focussing on closely-related
E. coli strains identified subtle differences in metabolite profiles
which may relate to adoption of specific lifestyles and potentially
contribute to interactions of these phenotypically distinct strains
with their host.
Preliminary metabolome analysis included ten
phylogenetically diverse E. coli encompassing representatives
of phylogroups A, B1, B2, D & E and comprising intestinal
pathogenic, extra-intestinal pathogenic, commensal and
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FIGURE 3 | Structures and MS/MS spectra from Citrulline (A) and Arginic acid (B) as found in supernatants of Nissle and CFT073, respectively. The two isomers
nearly co-elute under the chromatographic conditions used for this study. Only by MS/MS experiments it could be established that the C6H13N3O3 metabolite
released by the phylogenetically closely related strains CFT073 (as well as NCTC12241/ATCC25922) can be annotated as Arginic acid. Spectrum (A) from Nissle
could be matched to reference MS/MS spectra of Citrulline. Absent from (A), the most intense fragment in spectrum B obtained from CFT073 is C4H7O, which
indicates the likely presence of an C4-alkyl chain with a hydroxyl group (as present in Arginic acid); moreover, the CH5N3 fragment corresponding to the guanine
group of Arginic acid is also present in B and absent from A.
probiotic strains (Supplementary Table S1). Comparisons of
extracellular metabolomes indicated clear distinctions among
E. coli strains although it was not a goal to assess the extent
to which any differences corresponded with genotype as
phylogroups were mostly represented by one or two strains.
Nonetheless, our observation of strain-dependent metabolome
provides an initial perspective on the as yet unexplored level
in the metabolome diversity among E. coli strains and any
relatedness to metabolic capabilities, phylogenetic position and,
importantly, pathotype or other lifestyle trait.
Escherichia coli within phylogroup B2 includes intestinal
commensal strains and some enteric pathogens (such as
enteropathogenic strain E2348/69 and adherent-invasive strains
(such as LF82) associated with Crohn’s Disease) but is much
more typically associated with invasive or extra-intestinal
pathogenicity. These extra-intestinal pathogenic E. coli (ExPEC)
survive both within the intestinal tract and in other tissue sites
causing infections such as cystitis (UPEC), neonatal meningitis
(NMEC), sepsis (SEPEC) and pneumonia. These infections often
have severe clinical outcomes requiring extensive antibiotic and
supportive treatment, however these pathogenic classes within
E. coli phylogroup B2 are closely related to strains causing
asymptomatic infection [e.g., strain ABU83972; (Dobrindt et al.,
2016)] as well as the probiotic strain Nissle 1917 that has
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FIGURE 4 | (A) Average levels (counts/s) of a metabolite released only by Nissle in three independent experiments (Studies 1, 2, and 3). Note that the absolute levels
are dependent on many factors such as column bleeding, matrix effects, co-elution of metabolites, amongst others. The metabolite was not detected in any other
strain investigated. The elemental formula of C6H12N2O4 and its fragmentation spectrum shown in (B) indicate its relatness to Citrulline and Arginic acid. Via use of
MAGMa (see Supplementary Figure S3) and manual inspection of the MS/MS spectrum, the structural annotation of 5-(Carbamoylamino)-2-hydroxypentanoic acid
was established. Panel (C) shows the Nissle LC-MS/MS spectrum of N5-acetylornithine which was released by Nissle, CFT073, and NCTC12241/ATCC25922.
Note the absence of the NH3 loss in this spectrum. Other strains in the study released N2-acetylornithine (spectrum shown in (D) obtained from MG1655) or no
acetylornithine at all. Note the presence of the NH3 loss, indicative for the presence of an amine group not directly next to a carboxylic acid group. Spectrum D also
matched to reference spectra in the Metlin database. There was 0.4 min RT difference between the two N-acetylornithine isomers in the gradient used – with the N5
isomer eluting earlier.
been shown to show antagonistic effects on pathogenic E. coli
strains (Kleta et al., 2014; Rund et al., 2013). E. coli strains
CFT073, NCTC12241/ATCC25922, ABU83792 and Nissle are
reported as genomically closely related and share many virulence-
associated determinants (Supplementary Table S2; Dobrindt
et al., 2010; Hancock et al., 2010; Vejborg et al., 2010). Previously,
a comparative analysis of metabolic potential of E. coli (including
CFT073 and Nissle strains) using in silico approaches did not
identify any differences (Sun et al., 2005); however, metabolic
activities were not directly examined. Thus, our subsequent
metabolome analyses focussed on isolates within this closely-
related cluster to use the resolving capabilities of pHILIC coupled
to high-resolution MS-based metabolomics to assess whether any
of the strains could be distinguished in respect of extracellular
metabolome profiles.
The application of pHILIC based LC-MS metabolic profiling
of supernatants of distinct yet related E. coli strains revealed
substantial differences in their extracellular metabolic profiles –
verified in three independent analyses –, notably in metabolites
associated with Arginine biosynthesis (many of which form
part of the urea cycle in ureotelic organisms). Whilst B2
strains included in the focussed study possess Arginine
deiminase (and other Arginine biosynthesis enzymes), only
Nissle showed increased levels of Ornithine and Citrulline
as well as a structurally related novel bacterial metabolite
5-(Carbamoylamino)-2-hydroxypentanoic acid in supernatant.
These compounds differ through presence and/or position of
ketone and amide groups and, although it is tempting to speculate
that these may represent heretofore unrecognized intermediaries,
signaling molecules, or bioactives, any mechanism through
which these small molecular differences are established remains
to be elucidated.
A comparison of protein-coding sequences from CFT073,
NCTC12241/ATCC25922 and ABU_83972 identified 113
sequences which were conserved in these strains but divergent in
Nissle (Supplementary Table S3). Of these, only one protein was
annotated with function related to an Arginine-related metabolic
process; this enzyme – Arginine-N-succinyltransferase –
catalyzes the reaction succinyl-CoA + L-Arginine 
 CoA
+ N2−succinyl-L-Arginine, hence appears unlinked to
metabolites observed in Nissle but not the others. As noted
above (Figure 5B), there are no evident polymorphisms in
sequences of the Arginine biosynthesis-related enzymes that
may account for differences observed. Furthermore, it is not
evident that functional categorization of gene products from
operons co-ordinately regulated with Arginine biosynthesis loci
provide the necessary enzymatic activities to generate either
5-(Carbamoylamino)-2-hydroxypentanoic acid or Arginic acid;
however, it is conceivable that gene products currently annotated
as “hypothetical” may confer relevant biosynthetic capacities.
Coupled with metabolomics, extensive, systematic
interrogation of genes, operons and regulons in Nissle and
closely-related strain would be required to define which
gene products were involved in the observed divergence in
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FIGURE 5 | (A) Phylogenetic position of B2 strains in Studies 2 and 3 (B2-focussed and validation studies) on the B2 phylogroup phylogenetic tree – notice the thigh
grouping of NCTC12241/ATCC25922, Nissle 1917, and CFT073. (B) Schematic overview of Arginine biosynthesis relevant gene products with E. coli CFT073 as
model. Compounds identified and annotated in this study are indicated by underlining. Additional substrates and products are indicated in small lettering adjacent to
relevant enzymes. Dashed arrows indicate linkage to additional metabolic pathways. Comparative analysis showed identical Arginine deimidase (c5350 - enzyme EC
3.5.3.6) to be present in B2 strains Nissle, CFT073 and NCTC12241/ATCC25922. Identical amino acid sequences were also observed across these strains for
enzymes EC 6.3.4.5 (ArgG – c3929), EC 4.3.2.1 (ArgH – c4919), EC 2.1.3.3 (ArgI – c5353; c5348) & EC 3.5.1.16 (ArgE – c4916). Thus, E. coli strains Nissle 1971,
ABU87932 and NCTC12241/ATCC25922 share all indicated gene products whilst E. coli MG1655 lacks an orthologue of c5350 to interconvert Arginine and
Citrulline.
metabolomes among these strains. The influence of availability
of particular nutrients on metabolome is also a pertinent aspect.
For example, our own investigations with Campylobacter jejuni
(van der Hooft et al., 2018) have shown that supplementation of
defined medium with single components (glutamate or fucose)
can substantively affect extracellular metabolome composition.
Hence, it is conceivable that alteration of nutrient availability
may affect metabolome of E. coli strains and this issue will
be important to pursue in future investigations as this might
enable alteration in pathotype or even improvement in probiotic
functionality. This investigation presents multiple hypotheses for
further pursuit, notably the extent to which E. coli strains produce
similarly divergent metabolome profiles and comprehension of
association with pathotypes remains to be assessed.
The annotation of 5-(Carbamoylamino)-2-hydroxypentanoic
acid and the two N-Acetylornithine isomers as well as the
identification of Arginic acid do question whether the Arginine
biosynthesis pathway is completely characterized and further
characterization would be required to define the enzymes
contributing to synthesis of these “orphan” metabolites and,
potentially, their roles in physiology of these E. coli strains. With
complete genomes now available for an increasing amount of
bacterial strains including Nissle (Cress et al., 2013; Reister et al.,
2014), more insight in biosynthesis pathways and responsible
genes will hopefully accrue.
The novel insight into metabolic capacities of closely related
E. coli strains through high resolution metabolomics has
identified subtle differences in compound identities despite
presence of ostensibly identical Arginine biosynthetic pathways
in these strains. The specification of structurally distinct isomeric
compounds among these strains gives cause to postulate that
these may influence bacterial fitness and interactions within
their host. For instance, production and release of metabolites
such as indole-based metabolites or nucleotides by bacteria have
been linked to cellular, tissue, and host well-being (Idzko et al.,
2014; Berstad et al., 2015). Similarly, there are several studies
indicating that citrulline may have beneficial effects to the host
(Chapman et al., 2012; Bahri et al., 2013; Breuillard et al., 2015;
Antunes et al., 2016; Lai et al., 2017). In contrast, a study found
that Arginic Acid promotes oxidative damage (Delwing-de Lima
et al., 2017) and the molecule was found among a panel of
metabolites associated with chronic kidney disease (Zhang et al.,
2016). It is also noteworthy that Arginine metabolism has been
associated earlier to pathogenicity during an investigation of
Frontiers in Microbiology | www.frontiersin.org 9 February 2019 | Volume 10 | Article 252
fmicb-10-00252 February 19, 2019 Time: 12:39 # 10
van der Hooft et al. Differential Metabolome Among Closely-Related E. coli
the impact of expression of yersiniabactin-related genes on
the primary metabolism of E. coli (Lv and Henderson, 2011),
an iron uptake system present in B2 strains subject to
our focussed metabolome analysis. The potential biological
significance of single exported metabolites cannot be overlooked
- a recent report (Alvarez et al., 2017) identified that D-arginine
released by the enteric pathogen Vibrio cholerae results in
modulation of enteric microbiota. Whether Arginic acid,
Citrulline, Ornithine or other extracellular metabolites have
comparable bioactivities will be subject to confirmation through
further investigation.
The observation that only Nissle produced Citrulline
whereas pathogenic relatives produced Arginic acid, shows
unexpected correspondence to the pathotypes of the strains.
Any causal relationship between compound synthesis and
release with outcome during interaction with co-colonizers
or the host has yet to be established; however, it is clear
from this metabolomic study that the individual strains
show remarkable unexpected differences in their metabolic
capacities. Further determination will (i) require detailed
understanding of E. coli determinants responsible for synthesis
of these compounds, combined with structural confirmation
of compounds produced, (ii) investigation of the production
of arginine biosynthesis-related metabolites in more in vivo-
like settings, and (iii) establishing the potential influence of
Ornithine and Arginine on the host and co-colonizers of the
gut (the gut microbiota).
In summary, detailed and accurate metabolomic profiling
such as that in this study highlights how deepening
characterization of metabolic capabilities may make a
significant contribution to understanding bioactivities of
organisms. This metabolomics approach has offered novel
and intriguing insights into determinants of functional
differences between genetically closely related E. coli strains
which warrant further investigation into the contribution of
metabolites to probiotic and pathogenic characteristics. Just
after the centenary year of E. coli Nissle 1917 we establish
further its distinctiveness from related strains in extracellular
metabolome and reveal aspects that may contribute to its
potent probiotic characteristics and which are worthy of
further evaluation.
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